Cita APA

Montalván Ayala, V., Rojas Cheje, Z., & Aldave Salazar, R. (2022). Controversies in cerebrovascular disease: High or low doses of recombinant tissue plasminogen activator to treat acute stroke? A literature review.

Citación estilo Chicago

Montalván Ayala, V., Z. Rojas Cheje, y R. Aldave Salazar. Controversies in Cerebrovascular Disease: High or Low Doses of Recombinant Tissue Plasminogen Activator to Treat Acute Stroke? A Literature Review. 2022.

Cita MLA

Montalván Ayala, V., Z. Rojas Cheje, y R. Aldave Salazar. Controversies in Cerebrovascular Disease: High or Low Doses of Recombinant Tissue Plasminogen Activator to Treat Acute Stroke? A Literature Review. 2022.